Ampac Fine Chemicals

Published: 16-Aug-2007
Ingredients

Stand no: 9A96

Stand no: 9A96

Ampac Fine Chemicals is a technology-focused cGMP custom manufacturer of APIs and registered intermediates based in Sacramento, California.

We provide, at one site, process development and engineering, scale-up and cGMP manufacturing from kilogram to multi-tons using unique technologies.

We specialise in manufacturing of highly potent compounds (HPAPIs), handling of hazardous and energetic materials, continuous processing and continuous chromatography (SMB).

We provide our customers with economical solutions to challenging problems using a blend of unique technology and expertise in process development and engineering developed over the past 50 years.

  • Companies:
  • AMPAC Fine Chemicals
See more

You may also like

Ingredients

AMPAC registered as manufacturer of controlled substances

Read more
Plant upgrades extend capabilities at California facility

Trending Articles

  1. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  2. Logical Biological expands its raw pharma material development and supply capabilities with new lab The raw material supplier can now better serve in vitro diagnostic (IVD) manufacturers, as it has a significantly larger operational capacity
  3. Small molecules: big market opportunities The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will be fuelled by breakthroughs in this area, leading to a decline in the small molecule pipeline. This is far from true, notes Kevin Cook, Chief Executive Officer at Sterling Pharma Solutions; both are increasing and small molecule drugs continue to be a mainstay of many drug development portfolios
  4. Shasun Chemicals and Drugs Limited
  5. Olon Spa Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and biological processes while always embracing the highest international safety, quality, and environmental standards.

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Ingredients

AMPAC registered as manufacturer of controlled substances

Plant upgrades extend capabilities at California facility
Manufacturing

AMPAC to produce smallpox drug API for Chimerix

Will be manufactured in a remotely operated process plant
Ingredients

AMPAC Fine Chemicals expands production with plant in Texas

The addition of these facilities increases the firm’s total reactor capacity by approximately 30%
Manufacturing

Codexis partners Dishman and AMPAC Fine Chemicals

Codexis, a Californian biotechnology firm, has formed two separate pharmaceutical manufacturing partnerships with Dishman Pharmaceuticals and Chemicals and AMPAC Fine Chemicals (AFC), a subsidiary of American Pacific Corporation.
Distribution

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies
Ingredients

Rousselot and IamFluidics launch dissolvable microcarrier for cell culturing

The alginate and denatured collagen based product allows researchers to produce scalable cell cultures for biologic drugs and cell therapies
Ingredients

Therapeutic: vimseltinib for tenosynovial giant cell tumour

Tenosynovial giant cell tumour (TGCT) is a rare, non-malignant tumour that results from a translocation in the colony stimulating factor 1 (CSF1) gene
Subscribe now